July 24th, 2024 “EURETINA-Brief”© Issue No. 296
Dear EURETINA Members, A very warm welcome to the July 24th, 2024 edition of EURETINA’s web-based digital periodical, “EURETINA Brief”. EURETINA are delighted to continue…
EURETINA’s
DIGITAL
NEWSLETTER
Featured Articles
1
July 24th, 2024
Latest News
July 24th, 2024 “EURETINA-Brief”© Issue No. 296
Dear EURETINA Members, A very warm welcome to the July 24th, 2024 edition of EURETINA’s…
Re-purposed drugs for retinitis pigmentosa may address mutation-independent approach for retinal degenerations.
Researchers at the School of Pharmacy, University of Eastern Finland, and the Gavin Herbert Eye…
A first in-depth retrospective longitudinal study of Usher syndrome on USH1D, providing key natural history, image data and clinical features.
Researchers at UCL Institute of Ophthalmology, University College London, and Moorfields Eye Hospital, have reported…
Beacon Therapeutics has announced an investment of $170M for the development of ophthalmic gene therapies.
A private biotech company, Beacon Therapeutics, based in London, UK (and Florida and Cambridge, USA),…